We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.

eipglogo

The monthly European Industrial Pharmacists’ newsletter • March 2020

  • Technology & Production
    Looking for the solution against Covid-19
  • Politics & Business
    New M&A dynamics in an uncertain Covid-19 environment
  • Regulatory
    How the EU Commission and the European medicines regulatory network are handling the Covid-19 emergency
  • Focus on EU's Countries
    Pharma workforce is moving forward post Covid-19
  • EIPG
    EIPG: Consultations on Annex 21 and Annex 1, PharmSci podcast

Full information on this link

Newsletter (PDF)

 

eipglogo

The monthly European Industrial Pharmacists’ newsletter • April 2020

  • Technology & Production
      The impact of falsified medicines
  • Politics & Business
    The EU’s new Industrial and Pharmaceutical Strategies
  • Regulatory
    New guidances for gene therapy
  • Focus on EU's Countries
      Morocco: Drug Stock Management and Shortage Issues Related to Covid-19. Sharing the Moroccan Experience
  • EIPG
      EIPG: Talks by Prof Martini, consultation on Annex 1 and Covid-19
    related news

Newsletter (PDF)

eipglogo

The monthly European Industrial Pharmacists’ newsletter • March 2020

  • Technology & Production
      A new virus looking for effective treatments
  • Politics & Business
      The impact of Covid-19 on drug shortages
  • Regulatory
      Time to innovate the EU variation system
  • Focus on EU's Countries
      The Netherlands: Innovation in the academia and the industry
  • EIPG
      Message from the President and Advisory Group on Competencies

Full information on this link

Newsletter (PDF)

eipglogo

The monthly European Industrial Pharmacists’ newsletter • February 2020

  • The MDCG’s guideline on the cybersecurity of medical devices
  • Affordability and innovation for sustainable access to medicines
  • The principles to develop ePI
  • Lithuania: The status of HTA
  • Calls for consultation on GMP and the 1st webinar of 2020

Full information on this link

The last EIPG Newesletter is available:

eipglogo

  • Technology & Production
    Science Europe’s report on interdisciplinarity of research
  • Politics & Business
    The new EU Commissioners for Health and Research: proposals and suggestions for their action
  • Regulatory
    A Staff Working Document on EMA’s fees published by the EU Commission
  • Focus
    Verification, review, and check: approximation and implementation in terms of data integrity
  • EIPG
    Draft Code of Practice for Qualified Persons and other news from EIPG

More information on the EIPG website

EIPG2019 1This year, the General Assembly (GA) of the European Industrial Pharmacists Group (EIPG) took place in Budapest (Hungary) from 24 May to 26 May 2019. Alexia Rensonnet and Thomas Lion (board members and EIPG delegates) represented the Belgian Association.
The GA started with a scientific symposium entitled “Crossing the bridge: A current overview of the Falsified Medicines Directive” with five different speakers from the EFPIA, EIPG, Hungarian associations and companies. Piero Iamartino from EIPG presented the draft of the guidance on “Safety features implementation and QP responsibilities”.

During the GA, the Belgian Association UPIP-VAPI was mentioned several times and recognized for its pertinent contribution to the work of EIPG; for instance, for the review of QP code of conduct, a part concerning the good distribution practices (GDP) was added thanks to Belgium or for the contribution to the newsletter from EIPG in February. Moreover, Belgium is also well represented among the members visiting EIPG website or taking part in the proposed webinars.EIPG2019 2
During the GA, two working groups were also organized on Saturday. The first was entitled: “Professional Codes of Conduct and Legislation Requirements” and discussed the following question “What is the position of the industrial pharmacist in today’s industry?” and compared the requirements in the legislation for the different positions in the pharmaceutical industry in function of the countries in the European Union. For example, in the Belgian legislation, the role of the pharmacist is well mentioned and described which is not the case in all other countries. The goal of the discussion was to determine “How can we defend the pharmacist further in the European regulation?”.

The second was entitled: “Competences and Industrial Pharmacy Education” and considered the competences needed for the industrial pharmacist in the future following the new trends in the industry.

On the last day, Belgium presented to the other countries the activities organized by our association (UPIP-VAPI is one of the most active European associations) but also the hot topics in Belgium in our sector: drug shortages and the new Belgian law, the implementation of the falsified medicines directive in our country with the transition period, the increase of clinical trials and the pressure on the solidarity health insurance.

The next GA will take place in Leiden in May 2020.

 

FAGG-AFMPS is issuing its annual report that you can discover in the documents attached on the links below.

The minutes of the Strategies & Qualification methodologies for Visual Inspection meeting

The minutes are here (pdf)

Seminar on “New and Emerging Regulations”,

Sldeshows and minutes

A survey on potential future role for pharmacists in the pharmaceutical industry

twitterlinkedinfacebook2